Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Totally 83 (63.4%) of patients achieved histological regression at 78 weeks, and 48 (36.6%) were classified to the non-regression group
We currently understand its primary actions to be: GLP-1 (Glucagon-Like Peptide-1) Receptor Agonism: This action is known to enhance insulin secretion in a glucose-dependent manner, slow gastric emptying, and significantly suppress appetite by acting on the central nervous system
License: CC BY-NC-SA 3.0 IGO Article reviewed by: Samantha Flanagan, DO Dr
PMID: 3098458
US$ 21.08
US$ 28.57
US$ 27.77
US$ 29.60
US$ 24.59
